SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Pharmaceuticals to invest up to Rs 30 crore in VKT Pharma

17 Aug 2013 Evaluate

SMS Pharmaceuticals has received an approval to invest up to Rs 30 crore in VKT Pharma by way of equity participation subject to necessary approvals. The board of director at its meeting held on August 13, 2013 has approved for the same.

The board has also considered and authorized the CMD to evaluate the possibilities of the low-performing assets to consolidate with existing facilities to reduce the operating overheads and also for better utilization of the said facilities.

SMS Pharmaceuticals is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and its intermediates. The company has six manufacturing facilities and two R&D facilities located in Andhra Pradesh.

SMS Pharmaceuticals Share Price

402.70 -3.40 (-0.84%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: